Elevated plasma concentrations of interferon (IFN)-γ and the IFN-γ- inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1878-1885

  Lauw, Fanny N ^a   Simpson, Andrew J H ^b,d   Prins, Jan M ^a   Smith, Michael D ^b,d   Kurimoto, Masashi ^e   Van Deventer, Sander J H ^a   Speelman, Peter ^a   Chaowagul, Wipada ^c   White, Nicholas J ^b,d   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Sappasitthiprasong Hospital   (Thailand)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18;

ADULT; ARTICLE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; PATHOGENESIS; PRIORITY JOURNAL; SEPSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; CEPHALOSPORINS; FEMALE; HUMANS; IMIPENEM; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; INTERLEUKIN-18; INTERLEUKINS; MALE; MELIOIDOSIS; MIDDLE AGED; THIENAMYCINS;

EID: 0032708938     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315155     Document Type: Article

References (44)

1. 1. Chaowagul W, White NJ, Dance DA, et al. Melioidosis: a major cause of community-acquired septicemia in Northeastern Thailand. J Infect Dis 1989; 159:890-9.
2. 2. White NJ, Dance DA, Chaowagul W, Wattanagoon Y, Wuthiekanun V. Pitakwatchara N. Halving of mortality of severe melioidosis by ceftazidime. Lancet 1989; 2:697-701.
3. 3. Ip M, Osterberg LG, Chau PY, Raffin TA. Pulmonary melioidosis. Chest 1995; 108:1420-4.
4. 4. Suputtamongkol Y, Kwiatkowski D, Dance DA, Chaowagul W, White NJ. Tumor necrosis factor in septicemic melioidosis. J Infect Dis 1992; 165: 561-4.
5. 5. Friedland JS, Suputtamongkol Y, Remick DG, et al. Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyle interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect Immun 1992; 60:2402-8.
6. 6. Brown AE, Dance DA, Suputtamongkol Y, et al. Immune cell activation in melioidosis: increased serum levels of interferon-gamma and soluble interleukin-2 receptors without change in soluble CD8 protein. J Infect Dis 1991; 163:1145-8.
7. 7. Santanirand P, Harley VS, Dance DA, Raynes JG, Drasar BS, Bancroft GJ. Interferon-gamma mediates host resistance in a murine model of melioidosis. Biochem Soc Trans 1997; 25:287S.
8. 8. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15:749-95.
9. 9. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994; 84:4008-27.
10. 10. Okamura H, Tsutsi H, Komatsu T, et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995: 378:88-91.
11. 11. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol 1998; 10:259-64.
12. 12. Dinarello CA, Novick D, Puren AJ, et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol 1998; 63:658-64.
13. 13. Takeda K, Tsutsui H, Yoshimoto T, et al. Defective NK cell activity and Th1 response in IL-18 deficient mice. Immunity 1998;8:383-90.
14. 14. Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-gamma inducing factor and regulates LPS-induced IFN-gamma production. Nature 1997; 386:619-23.
15. 15. Gu Y, Kuida K, Tsutsui H, et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science 1997; 275:206-9.
16. 16. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA. Interleukin-18 regulation of interferon gamma production and cell proliferation as shown in interleukin-1beta converting enzyme (caspase-1) deficient mice. Blood 1998;91:2118-25.
17. 17. Yoshimoto T, Takeda K, Tanaka T, et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 1998; 161:3400-7.
18. 18. Carson WE, Giri JG, Lindemann MJ, et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994; 180:1395-403.
19. 19. Carson WE, Ross ME, Baiocchi RA, et al. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. J Clin Invest 1995;96:2578-82.
20. 20. Simpson AJ, Suputtamongkol Y, Smith MD, et al. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis 1999; 29:381-7
21. 21. Walsh AL, Smith MD, Wuthiekanun V, et al. Immunofluorescence microscopy for the rapid diagnosis of melioidosis. J Clin Pathol 1994;47:377-9.
22. 22. Taniguchi M, Nagaoka K, Kunikata T, et al. Characterization of anti-human interleukin-18 (IL-18)/interferon-gamma inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA. J Immunol Methods 1997;206:107-13.
23. 23. Calandra T, Baumgartner JD, Grau GE, et al. Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immmunoglobulin Study Group. J Infect Dis 1990; 161:982-7.
24. 24. Hazelzet JA, Kornelisse RF, van der Pouw Kraan TC, et al. Interleukin 12 levels during the initial phase of septic shock with purpura in children: relation to severity of disease. Cytokine 1997;9:711-6.
25. 25. Jansen PM, van der Pouw Kraan TCTM, de Jong IW, et al. Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood 1996; 87:5144-51.
26. 26. Heinzel FP. The role of IFN-gamma in the pathology of experimental endotoxemia. J Immunol 1990; 145:2920-4.
27. 27. Car BD, Eng VM, Schnyder B, et al. Interferon gamma receptor deficient mice are resistant to endotoxic shock. J Exp Med 1994; 179:1437-44.
28. + human blood mononuclear cells. J Clin Invest 1998; 101:711-21.
29. 29. Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res 1997; 57:4557-63.
30. 30. Robinson D, Shibuya K, Mui A, et al. IGTF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFKB. Immunity 1997;7:571-81.
31. 31. Ohtsuki T, Micallef MJ, Kohno K, Tanimoto T, Ikeda M, Kurimoto M. Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 1997;17:3253-8.
32. 32. Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Crptococcus neoformans through production of gamma interferon by natural killer cells. Infect Immun 1997;65:3594-9.
33. 33. Micallef MJ, Ohtsuki T, Kohno K, et al. Interferon-gamma inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur J Immunol 1996;26:1647-51.
34. 34. Yoshimoto T, Okamura H, Tagawa YI, Iwakura Y, Nakanishi K. Interleukin-18 together with interleukin-12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc Natl Acad Sci USA 1997;94:3948-53.
35. 35. Kawakami K, Qureshi MH, Zhang T. Okamura H, Kurimoto M, Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production. J Immunol 1997;159:5528-34.
36. 36. Mastroeni P, Clare S, Khan S, et al. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium. Infect Immun 1999;67:478-83.
37. 37. Lauw FN, Dekkers PEP, Te Velde AA, et al. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 1999;179:646-52.
38. 38. Wysocka M, Kubin M, Vieira LQ, et al. Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol 1995;25:672-6.
39. 39. Gately MK, Renzetti LM, Magram J, et al. The interleukin-12/interleukin-12 receptor system: role in normal and pathologic immune responses. Annu Rev Immunol 1998;16:495-521.
40. 40. Heinzel FP, Hujer AM, Ahmed FN, Rerko RM. In vivo production and function of IL-12 p40 homodimers. J Immunol 1997;158:4381-8.
41. + IFN-gamma producing cells. J Immunol 1997;158: 643-8.
42. 42. Kennedy MK, Park LS. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex. J Clin Immunol 1996;16:134-43.
43. 43. McInnes IB, al-Mughales J, Field M, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996;2: 175-82.
44. 44. Agostini C, Trentin L, Facco M, et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol 1996;157:910-8.